A transformative approach integrating advances in cellular therapy, gene engineering, and precision medicine to redefine how malignancies are treated at the biological level.
Gene Editing
Precision Targeting
Smart Therapies
Transferring engineered cells to boost immune response.
Modifying immune effector cells (e.g., using viral vectors or CRISPR) to target cancer.
Identifying tumor-associated antigens with high fidelity.
Ensuring long-term persistence to prevent recurrence.
Treatment-resistant and relapsed cancers that no longer respond to chemotherapy.
Blood cancers where cellular therapies have shown curative potential.
Selected solid tumors currently under advanced clinical investigation with TILs and CAR-T.
Highly specific tumor targeting sparing healthy cells.
Reduced off-target toxicity compared to systemic chemo.
Next-Generation Oncology marks a decisive shift toward precision-driven, immune-based cancer treatment, offering patients innovative therapies that reflect the future of oncology science. We are moving from treating the disease to empowering the patient's own body to cure it.
Revolutionizing cancer treatment with CAR-T cell engineering and personalized immunological solutions
Folkart Time Bornova Sitesi, Kazımdirik, 284. Sk. No:2 D:613, 35100 Bornova/İzmir, Turkey
